Bartolomei, M <br/><br/>
Combined treatment of glioblastoma patients with locoregional pre-targeted 90Y-biotin radioimmunotherapy and temozolomide.  [electronic resource] 

 -  The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of...  Sep 2004 
 - 220-8 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>1824-4785 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents, Alkylating--administration & dosage<br/>Biotin--therapeutic use<br/>Brain Neoplasms--diagnosis<br/>Chemotherapy, Adjuvant--methods<br/>Combined Modality Therapy<br/>Dacarbazine--administration & dosage<br/>Disease-Free Survival<br/>Drug Delivery Systems--methods<br/>Female<br/>Glioblastoma--diagnosis<br/>Humans<br/>Italy--epidemiology<br/>Male<br/>Middle Aged<br/>Radioimmunotherapy--methods<br/>Radiopharmaceuticals--therapeutic use<br/>Survival Analysis<br/>Temozolomide<br/>Treatment Outcome<br/>Yttrium Radioisotopes--therapeutic use